When.com Web Search

  1. Ads

    related to: glaxosmithkline pharma share price

Search results

  1. Results From The WOW.Com Content Network
  2. GlaxoSmithKline Pharmaceuticals - Wikipedia

    en.wikipedia.org/.../GlaxoSmithKline_Pharmaceuticals

    GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. [ 4 ] [ 5 ] The company's product portfolio includes prescription medicines and vaccines .

  3. GSK plc - Wikipedia

    en.wikipedia.org/wiki/GSK_plc

    GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.

  4. List of largest biomedical companies by revenue - Wikipedia

    en.wikipedia.org/wiki/List_of_largest_biomedical...

    The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.

  5. Did You Miss GlaxoSmithKline Consumer Healthcare's (NSE ... - AOL

    www.aol.com/news/did-miss-glaxosmithkline...

    By buying an index fund, you can roughly match the market return with ease. But if you buy good businesses at...

  6. GSK to cap out-of-pocket inhaler costs in US - AOL

    www.aol.com/news/gsk-cap-pocket-inhaler-costs...

    US lawmakers in January had criticized the top four inhalers manufacturers — AstraZeneca, Boehringer, Teva Pharmaceuticals and GSK — over high prices, and launched an investigation to look ...

  7. Analysis-Ozempic on Wall Street's list for 2027 ... - AOL

    www.aol.com/news/analysis-ozempic-wall-streets...

    Now that the U.S. government has negotiated prices for some Medicare program drugs effective in 2026, Wall Street analysts are betting on a 2027 list that will include Novo Nordisk's blockbuster ...